These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29299119)

  • 21. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW; Feldman EC; Shinsako J
    Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer.
    Lindhe O; Skogseid B
    Horm Metab Res; 2010 Sep; 42(10):725-30. PubMed ID: 20665429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation and characterization of a mitotane-resistant adrenocortical cell line.
    Seidel E; Walenda G; Messerschmidt C; Obermayer B; Peitzsch M; Wallace P; Bahethi R; Yoo T; Choi M; Schrade P; Bachmann S; Liebisch G; Eisenhofer G; Beule D; Scholl UI
    Endocr Connect; 2020 Feb; 9(2):122-134. PubMed ID: 31910152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma.
    Doghman M; Lalli E
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):66-9. PubMed ID: 23906534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical treatment using mitotane for adrenocortical carcinoma.
    Terzolo M; Zaggia B; Allasino B; De Francia S
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):159-65. PubMed ID: 24732405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late recurrence of operated adrenocortical carcinoma: atrial natriuretic factor before and after treatment with mitotane.
    Donckier JE; Michel LA; Berbinschi A; De Coster PM; De Plaen JF; Ketelslegers JM; Buysschaert M
    Surgery; 1989 May; 105(5):690-2. PubMed ID: 2523092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease.
    Salenave S; Bernard V; Do Cao C; Guignat L; Bachelot A; Leboulleux S; Droumaguet C; Bry-Gauillard H; Pierre P; Crinière L; Santulli P; Touraine P; Chanson P; Schlumberger M; Maiter D; Baudin E; Young J
    Eur J Endocrinol; 2015 Feb; 172(2):141-9. PubMed ID: 25411236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study.
    Bukowski RM; Wolfe M; Levine HS; Crawford DE; Stephens RL; Gaynor E; Harker WG
    J Clin Oncol; 1993 Jan; 11(1):161-5. PubMed ID: 8418229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
    Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma.
    Kroiss M; Quinkler M; Lutz WK; Allolio B; Fassnacht M
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):585-91. PubMed ID: 21883349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the function of mitochondria-associated ER membranes.
    Area-Gomez E
    Methods Enzymol; 2014; 547():181-97. PubMed ID: 25416359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid hormone synthesis in mitochondria.
    Miller WL
    Mol Cell Endocrinol; 2013 Oct; 379(1-2):62-73. PubMed ID: 23628605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal proteins bound by a reactive intermediate of mitotane.
    Cai W; Counsell RE; Schteingart DE; Sinsheimer JE; Vaz AD; Wotring LL
    Cancer Chemother Pharmacol; 1997; 39(6):537-40. PubMed ID: 9118466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance.
    Rieusset J; Fauconnier J; Paillard M; Belaidi E; Tubbs E; Chauvin MA; Durand A; Bravard A; Teixeira G; Bartosch B; Michelet M; Theurey P; Vial G; Demion M; Blond E; Zoulim F; Gomez L; Vidal H; Lacampagne A; Ovize M
    Diabetologia; 2016 Mar; 59(3):614-23. PubMed ID: 26660890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive treatment of adrenocortical carcinoma.
    Terzolo M; Berruti A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitotane for adrenocortical carcinoma treatment.
    Hahner S; Fassnacht M
    Curr Opin Investig Drugs; 2005 Apr; 6(4):386-94. PubMed ID: 15898346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Cushing's syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para'-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center.
    Donadille B; Groussin L; Waintrop C; Abbas H; Tenenbaum F; Dugué MA; Coste J; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):537-44. PubMed ID: 20061433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitotane exhibits dual effects on steroidogenic enzymes gene transcription under basal and cAMP-stimulating microenvironments in NCI-H295 cells.
    Lin CW; Chang YH; Pu HF
    Toxicology; 2012 Aug; 298(1-3):14-23. PubMed ID: 22546480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model.
    Hantel C; Jung S; Mussack T; Reincke M; Beuschlein F
    Endocr Relat Cancer; 2014 Jun; 21(3):383-94. PubMed ID: 24532475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma.
    Reimondo G; Puglisi S; Zaggia B; Basile V; Saba L; Perotti P; De Francia S; Volante M; Zatelli MC; Cannavò S; Terzolo M
    Eur J Endocrinol; 2017 Oct; 177(4):361-367. PubMed ID: 28780517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.